September 30, 2026

ACCESS Newswire
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis

Skymantics Europe Leverages DataGenesis to Power Next-Gen European Digital Twins with High-Fidelity Synthetic Populations

GA-ASI Achieves New Milestone With Semi-Autonomous CCA Flight

U.S. Polo Assn. Unveils Experiential USPA Shop Flagship at the USPA National Polo Center

U.S. Marine Corps Selects GA-ASI for MUX TACAIR Collaborative Combat Aircraft Program

Changing Your Dog’s Diet May Help the Planet More Than Changing Your Own, Study Finds

Reco Raises $30M B Round for a Total of $85M to Meet Rapidly Growing Demand for AI SaaS Security Among Enterprises

Logista Strator And Shekel Sign an Agreement to Bring Innovendi Elite to Spain – The Autonomous Sales Solution That Boosts Sales

Datavault AI Recaps High-Impact Super Bowl LX Weekend with NFL Alumni, Live ADIO(R) Activations, DVHOLO(TM) and Tokenization

Ore Energy Completes EU-Funded Multi-Day Energy Storage Pilot At EDF R&D Laboratories In France

Weed.de Warns: Proposed Cannabis Amendment Threatens Patient Access to Care

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
